AbCellera Biologics Inc.

ABCL

$11.57

+1.85%

N/A+$0.21

Healthcare

Biotechnology

NASDAQ

Active Trading

AbCellera Biologics Inc. specializes in pioneering an advanced platform for the discovery of antibodies. This comprehensive, AI-driven system meticulously explores and analyzes ...

Insider Transactions of ABCL

Acquisitions (A)

Since Jun 11, 2026

Disposals (D)

Since Jun 11, 2026

Monthly shares of acquisitions/disposals with close price trend (shared daily price source)

Insider Trading Snapshot

Date	Executive	Title	Security	Side	Shares	Price
Aug 24, 2026	Hayden Michael R	director	Common Shares	A	53,613	$10.64
Aug 18, 2026	Montalbano John S.	director	Common Shares	A	10,000	$11.03
Aug 14, 2026	Booth Andrew	officer: Chief Financial Officer	Common Shares	A	37,200	$10.32
Aug 12, 2026	Hayden Michael R	director	Common Shares	A	46,387	$10.37
Aug 11, 2026	Hayden Michael R	director	Common Shares	D	50,000	—

Insider Trading Snapshot

Acquisitions (A)

Disposals (D)

Total Shares Bought

675,016

Total Shares Sold

50,000

Monthly Insider Activity

Monthly shares of acquisitions/disposals with close price trend (shared daily price source)

Transactions by Title - Shares

X-axis: shares, sorted by total shares desc

Transactions by Title - Counts

X-axis: counts, sorted by A+D counts desc

Key People: Buy/Sell Activity and Price

Hayden Michael R

director • 4 txns

Seely Lynn

director • 2 txns

Montalbano John S.

director • 1 txns

Booth Andrew

officer: Chief Financial Officer • 1 txns

Transactions Table

Date	Executive	Title	Security	Side	Shares	Price	Value
Aug 24, 2026	Hayden Michael R	director	Common Shares	A	53,613	$10.64	$570,442.32
Aug 18, 2026	Montalbano John S.	director	Common Shares	A	10,000	$11.03	$110,300.00
Aug 14, 2026	Booth Andrew	officer: Chief Financial Officer	Common Shares	A	37,200	$10.32	$383,904.00
Aug 12, 2026	Hayden Michael R	director	Common Shares	A	46,387	$10.37	$481,033.19
Aug 11, 2026	Hayden Michael R	director	Common Shares	D	50,000	—	—
Jul 1, 2026	Seely Lynn	director	Share option (right to buy)	A	152,207	$7.85	$1,194,824.95
Jul 1, 2026	Sandor Victor	director	Share option (right to buy)	A	152,207	$7.85	$1,194,824.95
Jun 30, 2026	Seely Lynn	director:	—	—	0	—	—
Jun 11, 2026	Hayden Michael R	director	Share option (right to buy)	A	111,701	$5.27	$588,664.27
Jun 11, 2026	Quake Stephen	director	Share option (right to buy)	A	111,701	$5.27	$588,664.27

Supply Chain of ABCL

RELATIONS

Upstream

Amazon Web Services (AWS)NASDAQ:AMZN Thermo Fisher Scientific Inc.NYSE:TMO Danaher Corporation (Cytiva/Beckman Coulter/SCIEX)NYSE:DHRMerck KGaA (MilliporeSigma)ETR:MRKAgilent Technologies Inc.NYSE:A Bio-Rad Laboratories Inc.NYSE:BIO Illumina Inc.NASDAQ:ILMN 10x Genomics Inc.NASDAQ:TXG

Downstream

Eli Lilly and CompanyNYSE:LLY AbbVie Inc.NYSE:ABBV Jazz Pharmaceuticals plcNASDAQ:JAZZ Regeneron Pharmaceuticals Inc.NASDAQ:REGN Gilead Sciences Inc.NASDAQ:GILD Biogen Inc.NASDAQ:BIIB Novartis AGNYSE:NVS Incyte CorporationNASDAQ:INCY Denali Therapeutics Inc.NASDAQ:DNLI Prelude Therapeutics Inc.NASDAQ:PRLD Everest Medicines Ltd.HKEx:1952 Teva Pharmaceutical Industries Ltd.NYSE:TEVA Pfizer Inc.NYSE:PFE

Proxies

Regeneron Pharmaceuticals Inc.NASDAQ:REGNMorphic Therapeutic Inc. (acq. by Eli Lilly)UnconfirmedImmunocore Holdings plcNASDAQ:IMCR BioNTech SENASDAQ:BNTX

About UsPrivacy PolicyTerms of ServiceDisclaimerStock DirectoryETFsIndices13F HoldingsAnalyst TargetsFree ToolsTechnology MapJoin our Slack

Plutux is not an investment adviser. Market data and AI-generated analysis are for information and education only, not investment advice. Disclaimer